SOBRsafe Inc. (NASDAQ: SOBR), a provider of next-generation alcohol detection technology, announced it has entered into definitive agreements for the immediate exercise of certain outstanding warrants at a reduced exercise price of $1.05 per share. The transaction is expected to generate gross proceeds of approximately $3.1 million before fees and expenses, providing the company with additional capital for working capital and general corporate purposes.
In connection with the warrant exercise, SOBRsafe will issue new unregistered Series E and Series F warrants to purchase an aggregate of 4.7 million shares. The offering is expected to close on or about July 16, 2026, with H.C. Wainwright & Co. serving as the exclusive placement agent.
This capital raise comes as SOBRsafe continues to commercialize its touch-based alcohol detection technology, which detects and reports the presence of alcohol emitted through the skin in real time. The company's solution does not require breath, blood, or urine samples, offering a passive and dignified approach to alcohol screening. Its backend data platform supports applications in behavioral health, family law, consumer markets, and licensing and integration.
The funding could accelerate SOBRsafe's expansion efforts, particularly as the company targets key markets such as court-ordered monitoring and workplace safety. The additional working capital may also support research and development, sales, and marketing initiatives.
For more information on SOBRsafe, visit the company's website at www.sobrsafe.com and stay updated with the latest news and updates in the company's newsroom at https://nnw.fm/SOBR.
